Results 111 to 120 of about 42,251 (222)

A Risk Developing Prominent Hyperphosphatemia Leading to Renal Failure in Cup‐Like Leukemia

open access: yes
eJHaem, Volume 7, Issue 2, April 2026.
Osamu Imataki   +3 more
wiley   +1 more source

A Novel Modified Bu/Vp16/cy/Flu/Ara‐C Conditioning Regimen Enhances Outcomes for High‐Risk Acute Lymphoblastic Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

open access: yesCancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Purpose Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) effectively treats high‐risk acute lymphoblastic leukemia (ALL), yet challenges persist due to post‐transplant relapse and conditioning regimen toxicities. The determination of an appropriate preconditioning regimen is critical to improving patient outcomes.
Xiaoyan Zhao   +6 more
wiley   +1 more source

Co‐Mutation of ASXL1 and KRAS Defines a Novel Ultra‐Adverse‐Risk Subtype of Acute Myeloid Leukemia in a Large‐Scale Cohort

open access: yesCancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background ASXL1 mutation acute myeloid leukemia represents a clinically aggressive subtype with heterogeneous outcomes. Current evidence remains inconclusive regarding the prognostic relevance of the KRAS mutation partner in AML with ASXL1 mutation.
Yijing Zhao   +12 more
wiley   +1 more source

Impact of High Serum Lysozyme Activity on Renal Function and Survival Outcomes in Transplant‐Eligible and Ineligible Acute Myeloid Leukemia

open access: yesCancer Medicine, Volume 15, Issue 3, March 2026.
At AML initial diagnosis, the lysozyme and creatinine levels were positively correlated. However, the effect of lysozyme levels on AML prognosis is limited, because renal function recovers in many patients with high‐lysozyme levels after chemotherapy. ABSTRACT Lysozyme‐induced nephropathy is a complication of chronic myelomonocytic leukemia and acute ...
Takafumi Tsushima   +8 more
wiley   +1 more source

Ten‐Year Outcome of a Patient With Concurrent Pelvic Myeloid Sarcoma and Underlying Chronic Myeloid Leukaemia in Chronic Phase: A Case Report and Literature Review

open access: yesCancer Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background Myeloid sarcoma is a rare solid tumour of immature myeloid precursors occurring in an extramedullary site. It often presents significant diagnostic and therapeutic challenges to clinical haematologists. Case We describe a previously healthy patient who presented simultaneously with hyperleucocytic chronic myeloid leukaemia in ...
Kar Ying Yong   +3 more
wiley   +1 more source

Protective Effects of Auricularia auricula Polysaccharides on Acute Lung Injury by Regulating Intestinal Flora and Metabolism

open access: yesFood Frontiers, Volume 7, Issue 2, March 2026.
Auricularia auricula polysaccharides (AAP; 100, 200, and 400 mg/kg) protect against acute lung injury (ALI) by dose‐dependently remodeling the gut microbiota and modulating associated metabolic pathways via the gut‐lung axis, thereby enhancing pulmonary anti‐inflammatory and antioxidant capacity to ultimately prevent tissue damage.
Haili Niu   +8 more
wiley   +1 more source

The Regulation of Vasomotor and Cardiorespiratory Pulsations Is Disrupted in Primary Central Nervous System Lymphoma: A Case–Control fMRI Study

open access: yesHuman Brain Mapping, Volume 47, Issue 4, March 2026.
Using fast functional MRI, we assessed low‐frequency oscillations arising from cardiorespiratory pulsations and oscillatory interaction between respiratory and cardiac pulsations in primary central nervous system lymphoma. Respiratory‐related oscillations showed brain‐wide increases with a link to mortality whereas increases in cardiovascular‐related ...
Valter Poltojainen   +15 more
wiley   +1 more source

Unraveling the role of TP53 mutations in myeloproliferative neoplasms: Molecular mechanisms of leukemic transformation

open access: yesHemaSphere, Volume 10, Issue 3, March 2026.
Abstract TP53 mutations are found in over 50% of tumor types, including myeloproliferative neoplasms (MPNs). MPNs are characterized by a chronic phase, which may progress to secondary acute myeloid leukemia (sAML). Here, we discuss the physiological functions of p53 in hematopoiesis and its deregulation in MPNs.
Suzana da Silva‐Benedito   +6 more
wiley   +1 more source

Anatomical Localization–Based Analysis of Relapsed Secondary Central Nervous System Aggressive B‐Cell Lymphoma (R‐SCNSL)

open access: yesHematological Oncology, Volume 44, Issue 2, March 2026.
ABSTRACT 162 patients with relapsed secondary central nervous system lymphoma (R‐SCNSL) (median age, 65 years; male, 59.9%) including central nervous system (CNS)‐only (n = 120) and concomitant CNS/systemic relapse (n = 42) were retrospectively analyzed.
Izel Okcu   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy